{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:59:06Z","timestamp":1779379146947,"version":"3.53.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jceh.2021.11.014","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T10:19:18Z","timestamp":1638181158000},"page":"6-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Liver Injury Following Tinospora Cordifolia Consumption: Drug-Induced AIH, or de novo AIH?"],"prefix":"10.1016","volume":"12","author":[{"given":"Einar S.","family":"Bj\u00f6rnsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J.","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2021.11.014_bib1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Spanish Group for the Study of\u00a0Drug-Induced Liver Disease","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.11.014_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.11.014_bib3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bj\u00f6rnsson","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.11.014_bib4","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Drug Induced Liver Injury Network (DILIN)","volume":"135","author":"Chalasani","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.11.014_bib5","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury","volume":"48","author":"Chalasani","year":"2015","journal-title":"The DILIN prospective study Gastroenterology"},{"key":"10.1016\/j.jceh.2021.11.014_bib6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40264-017-0547-9","article-title":"The incidence of drug- and herbal and dietary supplement-induced liver injury: preliminary findings from gastroenterologist-based surveillance in the population of the state of Delaware","volume":"40","author":"Vega","year":"2017","journal-title":"Drug Saf"},{"key":"10.1016\/j.jceh.2021.11.014_bib7","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ajg.2012.138","article-title":"A\u00a0prospective nationwide study of drug-induced liver injury in Korea","volume":"107","author":"Suk","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.11.014_bib8","first-page":"1380","article-title":"Incidence and etiology of drug-induced\u00a0liver injury in mainland China","volume":"107","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2021.11.014_bib9","first-page":"2671","article-title":"Herbal and dietary supplement-induced liver injury in Taiwan: comparison with conventional drug-induced liver injury","volume":"41","author":"Huang","year":"2019","journal-title":"Hepatology Int"},{"key":"10.1016\/j.jceh.2021.11.014_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jceh.2020.11.002","article-title":"The Indian network of Drug-induced liver injury: etiology, clinical features, outcomes and prognostic markers in 1288 patients","volume":"11","author":"Devarbhavi","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2021.11.014_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2021.06.021","article-title":"Herbal Immune booster-induced liver injury in the COVID-19 pandemic - a case series","author":"Nagral","year":"2021","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2021.11.014_bib12","unstructured":"https:\/\/herbs.indianmedicinalplants.info\/index.php\/61-guduci-tinospora-cordifolia."},{"key":"10.1016\/j.jceh.2021.11.014_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12906-021-03251-z","article-title":"Case series and review of Ayurvedic medication induced liver injury","volume":"21","author":"Karousatos","year":"2021","journal-title":"BMC Complementary Medicine and Therapies"},{"key":"10.1016\/j.jceh.2021.11.014_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"de Boer","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2021.11.014_bib16","article-title":"Infliximab-induced liver injury: clinical phenotypes, autoimmunity and the role of corticosteroid treatment","author":"Bj\u00f6rnsson","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2021.11.014_bib17","first-page":"918156","article-title":"Liver injury with features mimicking autoimmune hepatitis following the use of black cohosh","author":"Guzman","year":"2009","journal-title":"Case Report Med"},{"key":"10.1016\/j.jceh.2021.11.014_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4254\/wjh.v6.i3.150","article-title":"Khat (Catha Edulis) as a possible cause of autoimmune hepatitis","volume":"6","author":"Riyaz","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2021.11.014_bib19","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","article-title":"Drug-induced autoimmune-like hepatitis","volume":"56","author":"Czaja","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2021.11.014_bib20","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1572-0241.2004.30444.x","article-title":"The prevalence of autoantibodies and autoimmune hepatitis in patients with non alcoholic fatty liver disease","volume":"99","author":"Adams","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.11.014_bib21","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1007\/s10620-015-3795-5","article-title":"Autoimmune markers do not impact clinical presentation or natural history of steatohepatitis-related liver disease","volume":"60","author":"Ravi","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2021.11.014_bib22","doi-asserted-by":"crossref","unstructured":"Bernal W, Ma Y, Smith HS, Portmann B, Wendon J, Vergani D. The significance of autoantibodies and immunoglobulins in acute liver failure: A cohort study. Journal of Hepatology; 47: 664-670.","DOI":"10.1016\/j.jhep.2007.05.011"},{"key":"10.1016\/j.jceh.2021.11.014_bib23","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/hep4.1582","article-title":"Exploratory study of autoantibody profiling in drug-induced liver injury with an autoimmune phenotype","volume":"4","author":"Lammert","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2021.11.014_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12664-017-0815-8","article-title":"Clinical outcomes, histopathological patterns, and chemical analysis of Ayurveda and herbal medicine associated with severe liver injury\u2014a single-center experience from southern India","volume":"37","author":"Philips","year":"2018","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.jceh.2021.11.014_bib25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep4.1346","article-title":"The contents of herbal and dietary supplements implicated in liver injury in the United States are frequently mislabeled","volume":"3","author":"Navarro","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jceh.2021.11.014_bib26","first-page":"271","article-title":"Polygonum multiflorum: recent updates on newly isolated compounds, potential hepatotoxic compounds and their mechanisms","author":"Teka","year":"2021","journal-title":"J\u00a0Ethnopharmacol"},{"key":"10.1016\/j.jceh.2021.11.014_bib27","first-page":"1","article-title":"Influence factors on the hepatotoxicity of polygoni Multiflori Radix","author":"Wei","year":"2019","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.jceh.2021.11.014_bib28","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.3390\/nu12092796","article-title":"Chemical composition, bioactivity and safety aspects of Kuding tea-from beverage to herbal extract","volume":"12","author":"W\u00fcpper","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.jceh.2021.11.014_fur29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321005788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321005788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:07:55Z","timestamp":1760854075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688321005788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0973688321005788"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2021.11.014","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver Injury Following Tinospora Cordifolia Consumption: Drug-Induced AIH, or de novo AIH?","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2021.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}